Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 3546 entries
View as:

A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children

Phase: N/A Priority: Normal
NCT ID: NCT02542865 Org: User:
Start: 07/24/17 End: 07/06/18 Due: 07/06/19

A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

Phase: N/A Priority: Normal
NCT ID: NCT00405080 Org: User:
Start: 11/11/06 End: 01/05/07 Due: 01/05/08

Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)

Phase: N/A Priority: Normal
NCT ID: NCT04544995 Org: User:
Start: 10/06/20 End: 04/23/25 Due: 04/23/26

Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00259909 Org: User:
Start: 11/02/05 End: 11/07/06 Due: 11/07/07

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

Phase: N/A Priority: Normal
NCT ID: NCT00148902 Org: User:
Start: 04/28/03 End: 01/21/06 Due: 01/21/07

Treximet ™ Pharmacy Budget Impact Model Database Validation Study

Phase: N/A Priority: Normal
NCT ID: NCT01332500 Org: User:
Start: 07/31/09 End: 03/31/10 Due: 03/31/11

An Efficacy Study of Chlorhexidine Mouthwashes

Phase: N/A Priority: Normal
NCT ID: NCT01751178 Org: User:
Start: 10/31/12 End: 03/31/13 Due: 03/31/14

An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01453049 Org: User:
Start: 04/30/10 End: 10/31/10 Due: 10/31/11

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT02723773 Org: User:
Start: 04/16/16 End: 06/28/23 Due: 06/28/24

PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00733785 Org: User:
Start: 08/13/08 End: 11/28/08 Due: 11/28/09

Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)

Phase: N/A Priority: Normal
NCT ID: NCT03555890 Org: User:
Start: 05/18/18 End: 09/17/18 Due: 09/17/19

Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)

Phase: N/A Priority: Normal
NCT ID: NCT01406275 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.

Phase: N/A Priority: Normal
NCT ID: NCT00849134 Org: User:
Start: 11/17/08 End: 04/06/09 Due: 04/06/10

Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01262924 Org: User:
Start: 10/31/97 End: 12/31/98 Due: 12/31/99

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00139347 Org: User:
Start: 12/31/03 End: 03/31/07 Due: 03/31/08

Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00359177 Org: User:
Start: 12/01/05 End: 10/12/06 Due: 10/12/07

Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart

Phase: N/A Priority: Normal
NCT ID: NCT00411073 Org: User:
Start: 12/31/06 End: - Due: -

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00370227 Org: User:
Start: 10/31/06 End: 03/31/07 Due: 03/31/08

Food Effect Study of Linerixibat Tablets in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05435170 Org: User:
Start: 08/11/22 End: 10/10/22 Due: 10/10/23

Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02573870 Org: User:
Start: 12/01/15 End: 07/05/16 Due: 07/05/17

Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01767454 Org: User:
Start: 02/12/13 End: 09/04/15 Due: 09/04/16

Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00674583 Org: User:
Start: 05/09/08 End: 01/08/09 Due: 01/08/10

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT06740630 Org: User:
Start: 01/10/25 End: 05/13/27 Due: 05/13/28

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2

Phase: N/A Priority: Normal
NCT ID: NCT06790303 Org: User:
Start: 03/04/21 End: 09/23/21 Due: 09/23/22

A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin

Phase: N/A Priority: Normal
NCT ID: NCT01416350 Org: User:
Start: 03/30/11 End: 05/12/11 Due: 05/12/12